M&A Deal Summary

Syneos Health Acquires inVentiv Health

On May 10, 2017, Syneos Health acquired life science company inVentiv Health from Thomas H. Lee Partners for 4.6B USD

Acquisition Highlights
  • This is Syneos Health’s 2nd transaction in the Life Science sector.
  • This is Syneos Health’s largest (disclosed) transaction.
  • This is Syneos Health’s 2nd transaction in the United States.
  • This is Syneos Health’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2017-05-10
Target inVentiv Health
Sector Life Science
Buyer(s) Syneos Health
Sellers(s) Thomas H. Lee Partners
Deal Type Merger
Deal Value 4.6B USD
Advisor(s) Credit Suisse Investment Banking (Financial)
Weil Gotshal & Manges (Legal)

Target

inVentiv Health

Burlington, Massachusetts, United States
inVentiv Health, Inc. is a provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv offers convergent services that deliver extraordinary outcomes to clients whose goal is improving human life.

Search 200,388 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Syneos Health

Morrisville, North Carolina, United States

Category Company
Founded 2010
Sector Life Science
Revenue 4.4B USD (2020)
DESCRIPTION

Syneos Health is a fully integrated biopharmaceutical solutions organization built to accelerate customer success. Syneos Health translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Syneos Health was founded in 2010 and is based in Morrisville, North Carolina.


DEAL STATS #
Overall 2 of 7
Sector (Life Science) 2 of 3
Type (Merger) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 2 of 5
Year (2017) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-12 Kendle International

Cincinnati, Ohio, United States

Kendle International Inc., a clinical research organization, provides Phase I-IV clinical development services on a contract basis to the biopharmaceutical industry worldwide.

Buy $232M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-20 Kinapse

London, United Kingdom

Kinapse Ltd. is a provider of outsourced and consultancy services to the global life sciences industry with a particular focus on the areas of regulatory and compliance services. Kinapse is based in London, United Kingdom.

Buy -

Seller(S) 1

SELLER

Thomas H. Lee Partners

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1974
PE ASSETS 35.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Thomas H. Lee Partners (THL) is a private equity firm that seeks buyout, expansion, consolidation, distressed, and recapitalization investments across various industries. Sectors of interest include business and information services, consumer products/retail, financial services, healthcare, industrial, and media/communications. THL looks to invest $100 to $400 million in companies valued up to $2.5 billion. THL was formed in 1974 and is based in Boston, Massachusetts.


DEAL STATS #
Overall 35 of 54
Sector (Life Science) 2 of 3
Type (Merger) 2 of 2
State (Massachusetts) 4 of 5
Country (United States) 27 of 45
Year (2017) 1 of 3
Size (of disclosed) 3 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-14 MHS

Mount Washington, Kentucky, United States

MHS is a provider of e-commerce infrastructure, enabling systems automation for top logistics and e-commerce companies in the world. MHS services its customers and the parcel industry through best-in-class turnkey engineering design services, software, and equipment. MHS was founded in 1975 and is based in Mount Washington, Kentucky.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-12 GCA Services Group

Cleveland, Ohio, United States

GCA Services Group, Inc. is a provider of quality facility services, including janitorial/custodial services, contamination control for cleanroom manufacturing, facilities operations and maintenance services, grounds and athletic field management services, diversified staffing, and more.

Sell $1.3B